Abstract:Objective: To evaluate the efficacy and safety of injectable gatifloxacin. Methods; In this multicenter, single-blind, randomized comparative study, patients with infection of lower respiratory tract and urinary tract were allocated randomly to gatifloxacin group or levofloxacin group. In each group patients were given gatifloxacin or levofloxacin intrevenously for 3-5 d followed by oral formulation. Results: (1)The clinical effective rates (gatifloxacin vs. levofloxacin) were 92.4%(110/119) vs. 91.2%(114/ 125), being 94.296(65/69) vs. 90.296(65/72) for lower respiratory tract infections and 90.0% (45/50) vs. 92.5%(42/72) for urinary tract infections, respectively, there was no statistically significant difference between the two groups; (2)The total bacterial eradication rates were 94.0% (78/83) vs. 88.0% (81/92), being 89.2% (33/37) vs. 92.9% (39/42) for urinary tract infections, there was no statistically significant difference between the two groups; however, the bacterial eradication rate of gatifloxacin (97.8% , 45/46) was higher than that of levofloxacin (84. 3% , 43/51) in lower respiratory tract infections, the difference was statistically significant. (3)Drug-related adverse effects were 29.9% (38/127) in gatifloxacin group, higher than that in levofloxacin group 10.1% (13/129). This is due to more patients with phlebitis and gastrointestinal symptoms in gatifloxacin group than those in levofloxacin group. These drug-related events could be alleviated by slowing down the speed of infusion; the adverse effects of both groups were mild and tolerable, no discontinuation of treatment due to adverse reaction. Drug-related abnormal laboratory findings oc- carred in gatifloxacin group and levefloxacin group were 24. 8% (30 /121) and 22. 1 % (27 /112) respectively. All were mild and transient, and there was no statistically significant difference between the two groups. Conclusions: Gatifloxacin given intravenously used as initial therapy in infectious patients with systemic clinical manifestations and followed by oral administration for the completion of therapy may get satisfactory results. The clinical efficacy of gatifloxacin is as good as that of levofloxacin. The adverse reaction rate of gatifloxacin was slightly higher than that of levofloxacin, but all the reactions are mild and tolerable.

Compatibility of gatifloxacin for injection in metronidazole injection

Study on Stability of Omeprazole for Injection

Clinical randomized controlled trials of Gatifloxacin injection in the treatment of bacterial infections of lower respiratory tract and urinary tract

Double-blind Randomized Controlled Clinical Trial on Gatifloxacin Versus Levofloxacin Injection for Treating Acute Bacterial Infections

Preparation and Determination of Compound Ciprofloxacin Suppository

Randomized Controlled Study on Gatifloxacin and Levofloxacin Injection in the Treatment of Acute Gonococcal Urinary and Reproductive Tract Infections

Clinical Randomized Controlled Trials of Gatifloxacin Injection in Treatment of Bacterial Infections of Respiratory Tract

Adverse Drug Reactions Induced by Gatifloxacin:Analysis of 866 Cases During 2003～2006

Influences of Levofloxacin Salts on the Metabolism of Escherichia Coli by Microcalorimetry

Stability of cefmetazole-doxycycline mixtures in sodium chloride and dextrose injections

Pharmacokinetics of gatifloxacin mesylate tablet in healthy volunteers after a single oral administration

A Multicenter, Single-Blind, Randomized Comparison of Sequential Therapy of Gatifloxacin Versus Levofloxacin in the Treatment of Bacterial Infections

In vitro antibacterial activity study of gemifloxacin mesylate for injection

Pharmacokinetics of Gatifloxacin Tablet in Healthy Volunteers

Bacteriological Efficacy of Gatifloxacin Methanesulfonate Tablet on Acute Bacterial Infections

A clinical randomized controlled trial of pazufloxacin injection in treatment of bacterial infection in 111 patients

A Double-Blind, Randomized Controlled Clinical Study:Gatifloxacin Vs Levofloxacin in Treatment of 98 Patients with Urinary Tract Infections

A study on multi-dose pharmacokinetics of gatifloxacin mesylate in healthy volunteers

The Effects of Gatifloxacin or Ciprofloxacin Combined with Cefmetazole on Escherichia Coli in Vitro

A follow-up study of effects of gatifloxacin on blood glucose in inpatients

A Study on the Interaction Between Ofloxacin and Bovine Lactoferrin by Fluorescence Spectrophotometry